Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
See Latest ArticlesPhase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III
Annals of Neurology , 09/18/09
Kaufmann P et al. – CoQ10 at 2,700mg daily for 9 months shows insufficient promise to warrant Phase III testing. Given this outcome, the adaptive Phase II design incorporating a dose selection and a futility test avoided the need for a much larger conventional Phase III trial.
Related Articles
Vocal Cord Dysfunction in Amyotrophic Lateral Sclerosis: Four Cases and a Review of the Literature
Archives of Neurology, 11/19/09
Relevance Score: 82%
Cervical spondylotic amyotrophy presenting as dropped head syndrome
Clinical Neurology and Neurosurgery, 11/13/09
Relevance Score: 80%
Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis
European Journal of Neurology, 10/12/09
Relevance Score: 79%
Multidisciplinary care for adults with amyotrophic lateral sclerosis or motor neuron disease
Cochrane Reviews, 10/09/09
Relevance Score: 79%
In vitro neurotoxic properties and excitatory aminoacids concentration in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Relationship with the degree of certainty of disease diagnoses
Acta Neurologica Scandinavica, 10/08/09
Relevance Score: 79%
Today in Demyelinating Disorders...keeping you current
Receive free subspecialty "5-minute updates" via email
MRI-based functional neuroimaging in ALS: An update
Amyotrophic Lateral Sclerosis, 12/07/09
Cyanobacteria, neurotoxins and water resources: are there implications for human neurodegenerative disease
Amyotrophic Lateral Sclerosis, 12/07/09
Micro-ribonucleic acid profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47
Brain, 12/04/09
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Kinematic improvement following Botulinum Toxin-A injection in upper limb spasticity due to stroke
Journal of Neurology, Neurosurgery, and Psychiatry , 12/07/09
Gabapentin Enacarbil in Restless Legs Syndrome: A Phase 2b, 2-Week, Randomized, Double-Blind, Placebo-Controlled Trial
Clinical Neuropharmacology, 12/07/09
Inhibition of long-term potentiation by valproic acid through modulation of cyclic AMP
Epilepsia, 12/07/09
Sponsor
Article Search
Sponsor